These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17120877)
1. Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. Fischer B; Popova S; Rehm J; Ivsins A Can J Public Health; 2006; 97(5):384-7. PubMed ID: 17120877 [TBL] [Abstract][Full Text] [Related]
3. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States. Mack KA; Jones CM; Ballesteros MF MMWR Surveill Summ; 2017 Oct; 66(19):1-12. PubMed ID: 29049278 [TBL] [Abstract][Full Text] [Related]
4. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States. Mack KA; Jones CM; Ballesteros MF Am J Transplant; 2017 Dec; 17(12):3241-3252. PubMed ID: 29145698 [TBL] [Abstract][Full Text] [Related]
5. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Fischer B; Jones W; Rehm J Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):438-42. PubMed ID: 23319301 [TBL] [Abstract][Full Text] [Related]
6. Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis. Milloy MJ; Wood E; Reading C; Kane D; Montaner J; Kerr T Addiction; 2010 Nov; 105(11):1962-70. PubMed ID: 20825372 [TBL] [Abstract][Full Text] [Related]
7. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada. MacDougall L; Smolina K; Otterstatter M; Zhao B; Chong M; Godfrey D; Mussavi-Rizi A; Sutherland J; Kuo M; Kendall P PLoS One; 2019; 14(1):e0210129. PubMed ID: 30629607 [TBL] [Abstract][Full Text] [Related]
8. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study. Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802 [TBL] [Abstract][Full Text] [Related]
9. Illicit drug overdose deaths resulting from income assistance payments: Analysis of the 'check effect' using daily mortality data. Otterstatter MC; Amlani A; Guan TH; Richardson L; Buxton JA Int J Drug Policy; 2016 Jul; 33():83-7. PubMed ID: 27402469 [TBL] [Abstract][Full Text] [Related]
10. Patterns of health care utilization among people who overdosed from illegal drugs: a descriptive analysis using the BC Provincial Overdose Cohort. Otterstatter MC; Crabtree A; Dobrer S; Kinniburgh B; Klar S; Leamon A; May-Hadford J; Mill C; Park M; Tu AW; Zheng L Health Promot Chronic Dis Prev Can; 2018 Sep; 38(9):328-333. PubMed ID: 30226726 [TBL] [Abstract][Full Text] [Related]
11. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study. Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561 [TBL] [Abstract][Full Text] [Related]
12. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898 [TBL] [Abstract][Full Text] [Related]
13. An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada. Richardson L; Geddes C; Palis H; Buxton J; Slaunwhite A Int J Drug Policy; 2024 Apr; 126():104362. PubMed ID: 38484530 [TBL] [Abstract][Full Text] [Related]
14. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621 [TBL] [Abstract][Full Text] [Related]
15. Trends and sex differences in prescription opioid deaths in British Columbia, Canada. Gladstone EJ; Smolina K; Morgan SG Inj Prev; 2016 Aug; 22(4):288-90. PubMed ID: 26195562 [TBL] [Abstract][Full Text] [Related]
16. "There are solutions and I think we're still working in the problem": The limitations of decriminalization under the good Samaritan drug overdose act and lessons from an evaluation in British Columbia, Canada. Xavier J; Greer A; Pauly B; Loyal J; Mamdani Z; Ackermann E; Barbic S; Buxton JA Int J Drug Policy; 2022 Jul; 105():103714. PubMed ID: 35561485 [TBL] [Abstract][Full Text] [Related]
17. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. Wallace B; Pagan F; Pauly BB Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237 [TBL] [Abstract][Full Text] [Related]
18. Does the inclusion of vehicle impoundment in provincial short-term administrative driver's license suspension programs reduce total and alcohol-related fatal collisions in Canada? Smith NK; Brubacher J; Andreou P; Asbridge M Traffic Inj Prev; 2019; 20(8):771-776. PubMed ID: 31647336 [No Abstract] [Full Text] [Related]
19. Spatial-temporal trends in the risk of illicit drug toxicity death in British Columbia. Hu K; Klinkenberg B; Gan WQ; Slaunwhite AK BMC Public Health; 2022 Nov; 22(1):2121. PubMed ID: 36401244 [TBL] [Abstract][Full Text] [Related]